Corrigendum to "Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not": [ESMO Open 8 (2023) 101645].

Autor: Zwart WH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen. Electronic address: w.h.zwart@umcg.nl., Dijkstra EA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen., Putter H; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden., Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Nilsson PJ; Department of Surgery, Karolinska University Hospital, Stockholm, Sweden., van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden., van Etten B; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen., Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Publikováno v: ESMO open [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102042. Date of Electronic Publication: 2023 Oct 20.

The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trial.

Autor: Dijkstra EA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: e.a.dijkstra@umcg.nl., Zwart WH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Nilsson PJ; Department of Surgery, Karolinska University Hospital, Stockholm, Sweden., Putter H; Departments of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands., Roodvoets AGH; Departments of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Meershoek-Klein Kranenbarg E; Departments of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Frödin JE; Department of Oncology-Pathology, Karolinska University Hospital, Uppsala., Nygren P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Østergaard L; Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark., Kersten C; Department of Research, Sørlandet Hospital Trust, Kristiansand, Norway., Verbiené I; Department of Oncology, Uppsala University, Uppsala, Sweden., Cervantes A; Department of Medical Oncology, Biomedical Research Institute Incliva, University of Valencia, Valencia, Spain., Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands., Capdevila J; Department of Medical Oncology, Vall Hebron Institute of Oncology (VHIO), Vall Hebron University Hospital. Autonomous University of Barcelona (UAB), Barcelona, Spain., Edhemovic I; Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., van de Velde CJH; Departments of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam; Department of Radiation Oncology, Leiden University Medical Center, Leiden., van Etten B; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Publikováno v: ESMO open [ESMO Open] 2023 Apr; Vol. 8 (2), pp. 101158. Date of Electronic Publication: 2023 Mar 03.

The Multimodal Management of Locally Advanced Rectal Cancer: Making Sense of the New Data.

Autor: Zwart WH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Hotca A; Department of Radiation Oncology, Mount Sinai, New York, NY., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Goodman KA; Department of Radiation Oncology, Mount Sinai, New York, NY., Garcia-Aguilar J; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2022 Apr; Vol. 42, pp. 1-14.

A multi-centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait.

Autor: Habr-Gama, Angelita^1,2,3 (AUTHOR), São Julião, Guilherme Pagin^2,3,4 (AUTHOR), Ortega, Cinthia D.^5,6 (AUTHOR), Vailati, Bruna Borba^2,3,4 (AUTHOR), Araujo, Sergio⁶ (AUTHOR), Jorge, Thiago⁷ (AUTHOR), Sabbaga, Jorge⁸ (AUTHOR), Rossi, Gustavo L.⁹ (AUTHOR), D'Alpino, Renata¹⁰ (AUTHOR), Kater, Fabio Roberto¹¹ (AUTHOR), Aguilar, Patricia Bailão¹² (AUTHOR), Mattacheo, Adrian¹³ (AUTHOR), Perez, Rodrigo Oliva^2,3,4,14 (AUTHOR) rodrigo.operez@gmail.com

Publikováno v: BMC Cancer. 6/14/2023, Vol. 23 Issue 1, p1-10. 10p.

Surveillance bei Watch-and-Wait nach neoadjuvanter Therapie beim Rektumkarzinom. (German)

Autor: Wiegering, Armin, Kastner, Carolin, Meir, Michael, Flemming, Sven, Reibetanz, Joachim, Germer, Christoph Thomas

Publikováno v: Tumordiagnostik & Therapie; Oct2024, Vol. 45 Issue 8, p532-539, 8p